Peptone
About:
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.
Website: https://peptone.io
Twitter/X: peptoneltd
Top Investors: Bessemer Venture Partners, F-Prime Capital, Founders Factory, Hoxton Ventures, Walden Catalyst
Description:
We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.
Total Funding Amount:
$42.4M
Headquarters Location:
London, England, United Kingdom
Founded Date:
2018-01-01
Contact Email:
partnering(AT)peptone.io
Founders:
Kamil Tamiola, Matt Heberling
Number of Employees:
11-50
Last Funding Date:
2022-06-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai